Clinical Trial Update: The Effect of PPI in Preventing Gastroesophageal Reflux Disease of Seafarers [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the effect of a proton pump inhibitor in preventing gastroesophageal reflux disease among seafarers; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Snippet

Sponsor: Fifth Affiliated Hospital, Sun Yat-Sen University | Conditions: Gastroesophageal Reflux Disease | Phase 3 | Status: UNKNOWN